Effects of duloxetine on motor and mood symptoms in Parkinson's disease: An open-label clinical experience

被引：13
|
作者：
Nishijima, Haruo [1 ,2 ]
Ueno, Tatsuya [1 ,2 ]
Kon, Tomoya [1 ]
Haga, Rie [1 ]
Funamizu, Yukihisa [1 ]
Arai, Akira [1 ]
Suzuki, Chieko [1 ]
Nunomura, Jin-ichi [1 ]
Baba, Masayuki [1 ]
Tomiyama, Masahiko [1 ,2 ]
机构：
[1] Aomori Prefectural Cent Hosp, Dept Neurol, 2-1-1 Higashi Tsukurimichi, Aomori 0308553, Japan
[2] Hirosaki Univ, Grad Sch Med, Inst Brain Sci, Dept Neurophysiol, Hirosaki, Aomori, Japan
来源：
JOURNAL OF THE NEUROLOGICAL SCIENCES | 2017年 / 375卷
关键词：
Duloxetine; Dyskinesia; Norepinephrine transporter; OFF time; Serotonin transporter; Parkinson's disease; L-DOPA; LEVODOPA; DEPRESSION; CITALOPRAM; DYSKINESIA; STRIATUM; REUPTAKE; MODEL;
D O I：
10.1016/j.jns.2017.01.066
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：186 / 189
页数：4
相关论文
共 50 条
  • [11] Effectiveness of Safinamide over Mood in Parkinson’s Disease Patients: Secondary Analysis of the Open-label Study SAFINONMOTOR
    Carmen M. Labandeira
    Maria G. Alonso Losada
    Rosa Yáñez Baña
    Maria I. Cimas Hernando
    Iria Cabo López
    Jose M. Paz González
    Maria J. Gonzalez Palmás
    Cristina Martínez Miró
    Diego Santos García
    Advances in Therapy, 2021, 38 : 5398 - 5411
  • [12] Effects of Rivastigmine on Tremor and Other Motor Symptoms in Patients with Parkinson’s Disease DementiaA Retrospective Analysis of a Double-Blind Trial and an Open-Label Extension
    Wolfgang Oertel
    Werner Poewe
    Erik Wolters
    Peter Paul De Deyn
    Murat Emre
    Courtney Kirsch
    Chuanchieh Hsu
    Sibel Tekin
    Roger Lane
    Drug Safety, 2008, 31 : 79 - 94
  • [13] Effects of rivastigmine on tremor and other motor symptoms in patients with Parkinson's disease dementia - A retrospective analysis of a double-blind trial and an open-label extension
    Oertel, Wolfgang
    Poewe, Werner
    Wolters, Erik
    De Deyn, Peter Paul
    Emre, Murat
    Kirsch, Courtney
    Hsu, Chuanchieh
    Tekin, Sibel
    Lane, Roger
    DRUG SAFETY, 2008, 31 (01) : 79 - 94
  • [14] Sustained effect of prasinezumab on Parkinson's disease motor progression in the open-label extension of the PASADENA trial
    Pagano, Gennaro
    Monnet, Annabelle
    Reyes, Adriana
    Ribba, Benjamin
    Svoboda, Hanno
    Kustermann, Thomas
    Simuni, Tanya
    Postuma, Ronald B.
    Pavese, Nicola
    Stocchi, Fabrizio
    Brockmann, Kathrin
    Smigorski, Krzysztof
    Gerbaldo, Valentina
    Fontoura, Paulo
    Doody, Rachelle
    Kerchner, Geoffrey A.
    Brundin, Patrik
    Marek, Kenneth
    Bonni, Azad
    Nikolcheva, Tania
    NATURE MEDICINE, 2024, 30 (12) : 3669 - 3675
  • [15] Evaluation of open-label rotigotine treatment in advanced Parkinson's disease
    Lyons, Kelly E.
    Pahwa, Rajesh
    Boroojerdi, Babek
    NEUROLOGY, 2008, 70 (11) : A59 - A59
  • [16] Management of punding in Parkinson’s disease: an open-label prospective study
    A. Fasano
    L. Ricciardi
    M. Pettorruso
    A. R. Bentivoglio
    Journal of Neurology, 2011, 258 : 656 - 660
  • [17] Management of punding in Parkinson's disease: an open-label prospective study
    Fasano, A.
    Ricciardi, L.
    Pettorruso, M.
    Bentivoglio, A. R.
    JOURNAL OF NEUROLOGY, 2011, 258 (04) : 656 - 660
  • [18] Evaluation of open-label rotigotine treatment in advanced Parkinson's disease
    Lyons, K. E.
    Pahwa, R.
    Boroojerdi, B.
    EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 : 118 - 118
  • [19] Evaluation of open-label rotigotine treatment in advanced Parkinson's disease
    Lyons, K. E.
    Pahwa, R.
    Boroojerdi, B.
    MOVEMENT DISORDERS, 2008, 23 (01) : S215 - S215
  • [20] Mood disturbances and cognitive functioning in Parkinson's disease: The effects of disease duration and side of onset of motor symptoms
    Foster, Paul S.
    Drago, Valeria
    Mendez, Kelli
    Witt, John C.
    Crucian, Gregory P.
    Heilman, Kenneth M.
    JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY, 2013, 35 (01) : 71 - 82
12345